Peyronie's disease following radical prostatectomy: Incidence and predictors

Journal of Sexual Medicine

Volumn 7, Issue 3, 2010, Pages 1254-1261

  Tal, Raanan ^a   Heck, Matthias ^a   Teloken, Patrick ^a   Siegrist, Timothy ^a   Nelson, Christian J ^a   Mulhall, John P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Incidence; Peyronie's disease; Predictors; Radical prostatectomy; Risk factors for peyronie's disease

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; DISEASE ASSOCIATION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PENIS ERECTION; PEYRONIE DISEASE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; RISK FACTOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT RESPONSE;

EID: 77950802445     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01655.x     Document Type: Article

References (16)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-49.
2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001, 88:727-30.
3. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, Natali A, Vaggi L, Catuogno C, Giustini M, Taggi F. Peyronie's disease: Prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol 2001, 40:525-30.
4. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004, 171:2350-3.
5. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005, 173:1673-6.
6. Bjekic MD, Vlajinac HD, Sipetic SB, Marinkovic JM. Risk factors for Peyronie's disease: A case-control study. BJU Int 2006, 97:570-4.
7. Carrieri MP, Serraino D, Palmiotto F, Nucci G, Sasso F. A case-control study on risk factors for Peyronie's disease. J Clin Epidemiol 1998, 51:511-5.
8. Ciancio SJ, Kim ED. Penile fibrotic changes after radical retropubic prostatectomy. BJU Int 2000, 85:101-6.
9. Ohebshalom M, Mulhall J, Guhring P, Parker M. Measurement of penile curvature in Peyronie's disease patients: Comparison of three methods. J Sex Med 2007, 4:199-203.
10. Deveci S, Hopps CV, O'Brien K, Parker M, Guhring P, Mulhall JP. Defining the clinical characteristics of Peyronie's disease in young men. J Sex Med 2007, 4:485-90.
11. El-Sakka AI. Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol 2006, 49:564-9.
12. Babyak MA. What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004, 66:411-21.
13. Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodosio da Ros C, Ary Vargas Souto C. Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 2001, 13:291-3.
14. Smith BH. Subclinical Peyronie's disease. Am J Clin Pathol 1969, 52:385-90.
15. Tal R, Mulhall JP. Intracavernosal injections and fibrosis: Myth or reality? BJU Int 2008, 102:525-6.
16. Agrawal V, Ellins E, Donald A, Minhas S, Halcox J, Ralph DJ. Systemic vascular endothelial dysfunction in Peyronie's disease. J Sex Med 2008, 5:2688-93.